These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30626653)

  • 1. Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials.
    van Eijk RPA; Westeneng HJ; Nikolakopoulos S; Verhagen IE; van Es MA; Eijkemans MJC; van den Berg LH
    Neurology; 2019 Jan; 92(5):e451-e460. PubMed ID: 30626653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis.
    Jewett G; Khayambashi S; Frost GS; Beland B; Lee A; Hodgkinson V; Korngut L; Chhibber S
    Muscle Nerve; 2022 Oct; 66(4):397-403. PubMed ID: 35673968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.
    Fournier CN
    Neurotherapeutics; 2022 Jul; 19(4):1180-1192. PubMed ID: 35819713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS clinical trials: do enrolled patients accurately represent the ALS population?
    Chiò A; Canosa A; Gallo S; Cammarosano S; Moglia C; Fuda G; Calvo A; Mora G;
    Neurology; 2011 Oct; 77(15):1432-7. PubMed ID: 21956723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.
    Gandhi M; Ameli N; Bacchetti P; Sharp GB; French AL; Young M; Gange SJ; Anastos K; Holman S; Levine A; Greenblatt RM
    AIDS; 2005 Nov; 19(16):1885-96. PubMed ID: 16227797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.
    Diana A; Pillai R; Bongioanni P; O'Keeffe AG; Miller RG; Moore DH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006049. PubMed ID: 28067943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order.
    van Eijk RPA; Nikolakopoulos S; Roes KCB; Kendall L; Han SS; Lavrov A; Epstein N; Kliest T; de Jongh AD; Westeneng HJ; Al-Chalabi A; Van Damme P; Hardiman O; Shaw PJ; McDermott CJ; Eijkemans MJC; van den Berg LH
    Neurology; 2021 Sep; 97(11):528-536. PubMed ID: 34315786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A literature review of the impact of exclusion criteria on generalizability of clinical trial findings to patients with chronic pain.
    Salmasi V; Lii TR; Humphreys K; Reddy V; Mackey SC
    Pain Rep; 2022; 7(6):e1050. PubMed ID: 36398200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
    Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Hoertel N; Le Strat Y; Lavaud P; Dubertret C; Limosin F
    J Clin Psychiatry; 2013 Mar; 74(3):265-70. PubMed ID: 23561233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Residual Risk-Based Eligibility vs Tumor Size and Nodal Status for Power Estimates in Adjuvant Trials of Breast Cancer Therapies.
    Wei W; Kurita T; Hess KR; Sanft T; Szekely B; Hatzis C; Pusztai L
    JAMA Oncol; 2018 Apr; 4(4):e175092. PubMed ID: 29372234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review.
    Tavazzi E; Longato E; Vettoretti M; Aidos H; Trescato I; Roversi C; Martins AS; Castanho EN; Branco R; Soares DF; Guazzo A; Birolo G; Pala D; Bosoni P; Chiò A; Manera U; de Carvalho M; Miranda B; Gromicho M; Alves I; Bellazzi R; Dagliati A; Fariselli P; Madeira SC; Di Camillo B
    Artif Intell Med; 2023 Aug; 142():102588. PubMed ID: 37316101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies.
    Srikanthan A; Vera-Badillo F; Ethier J; Goldstein R; Templeton AJ; Ocana A; Seruga B; Amir E
    Cancer Treat Rev; 2016 Feb; 43():67-73. PubMed ID: 26827694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism.
    Mehta P; Raymond J; Han MK; Larson T; Berry JD; Paganoni S; Mitsumoto H; Bedlack RS; Horton DK
    J Med Internet Res; 2021 Dec; 23(12):e28021. PubMed ID: 34878988
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.